<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1463">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087825</url>
  </required_header>
  <id_info>
    <org_study_id>A15-D28-VOL.25</org_study_id>
    <nct_id>NCT03087825</nct_id>
  </id_info>
  <brief_title>Preoxygenation Method With a Calibrated Leak</brief_title>
  <official_title>Effect of Preoxygenation With Spontaneous Breathing or Noninvasive Positive Pressure Ventilation With or Without a Calibrated Leak. An Experimental Study in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During preoxygenation, imperfect seal between the face mask and patient's face can induce an
      inward air leak decreasing its effectiveness. We assume that noninvasive ventilation could
      cancel the effect of the leak.

      This is a prospective study. Healthy volunteers are randomised in cross-over between
      spontaeous breathing or noninvasive ventilation perssure support preoxygenation in the
      presence or absence of a calibrated leak on the inspiratory circuit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During preoxygenation, imperfect seal between the face mask and patient's face can induce an
      inward air leak decreasing its effectiveness. We assume that noninvasive ventilation could
      cancel the effect of the leak.

      We planned an experimental study with healthy volunteers (residents in anesthesiology).

      Healthy volunteers are randomised in cross-over between preoxygenatio through spontaeous
      breathing or noninvasive ventilation perssure support preoxygenation in the presence or
      absence of a calibrated leak on the inspiratory circuit. The inspiratory fraction of oxygen
      is 100%. The exhaled gas (oxygen and carbon dioxide) are monitored.The subjects breathed
      through a mouthpiece (with a nose clip) connected to an anesthetic ventilator.

      The primary endpoint is the time to achieve end expiratory fracion of oxygene of 90% or
      more.

      The secondary endpoint is the proportion of subject with end expiratory fracion of oxygene
      of 90% or more after a 3 min period (recommended in clinical guidelines).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>2 groups : spontaneous breathinh and non invasive pressure support ventilation 2 conditions : without inward air leak and with inward air leak</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>end expiratory fraction of oxygen</measure>
    <time_frame>10 minutes</time_frame>
    <description>end expiratory fraction of oxygen measured in exhaled gas</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Preoxygenation</condition>
  <condition>Non Invasive Ventilation</condition>
  <arm_group>
    <arm_group_label>spontaeous breathing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>preoxygenation through spontaneous breathing of 100% oxygen gas flow</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non invasive pressure support ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>preoxygenation through non invasive pressure support ventilation of 100% oxygen gas flow</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non invasive pressure support ventilation</intervention_name>
    <description>non invasive with +6cmH2O pressure support ventilation and +5cmH2O of positive end expiratory pressure</description>
    <arm_group_label>non invasive pressure support ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers

        Exclusion Criteria:

          -  any pathological condition

          -  active tobaco
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jean-luc hanouz, m.D,ph.d</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Caen and universite Caen Normandie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jean-luc hanouz, .D.,Ph.D.</last_name>
    <email>hanouz-jl@chu-caen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Caen</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jean-luc hanouz, md, phd</last_name>
      <phone>02 31 06 47 36</phone>
      <phone_ext>+33</phone_ext>
      <email>hanouz-jl@chu-caen.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>March 17, 2017</lastchanged_date>
  <firstreceived_date>March 17, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
